About this paper
Design of experiment (DOE) was utilized to optimize a peptide microarray to test autoantibodies in serum against various components of the myelin sheath. Incorporating the ideal assay conditions from a single DOE experiment versus multiple sequential experiments resulted in a reproducible serum assay with low variability, low nonspecific background, and a high level of distinction between multiple sclerosis (MS) and normal samples. A minimum set of peptides was found that achieved a sensitivity of 90 percent. Autoantibodies against each individual peptide were elevated in at least 35 percent of the individual MS patients tested.
Acerca de SAS
SAS es el líder en analítica. A través de software y servicios innovadores, SAS capacita e inspira a los clientes de todo el mundo para que transformen los datos en inteligencia. SAS ofrece THE POWER TO KNOW®.